Home/Filings/4/0001181431-10-013961
4//SEC Filing

HOBDEN ADRIAN N 4

Accession 0001181431-10-013961

CIK 0001459450other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:07 PM ET

Size

11.6 KB

Accession

0001181431-10-013961

Insider Transaction Report

Form 4
Period: 2010-03-02
HOBDEN ADRIAN N
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2010-03-022,0490 total
    Exercise: $1.34Exp: 2016-02-16Common Stock (2,049 underlying)
  • Exercise/Conversion

    Common Stock

    2010-03-02$1.34/sh+2,049$2,746114,782 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2010-03-022,4310 total
    Exercise: $1.13Exp: 2015-09-14Common Stock (2,431 underlying)
  • Exercise/Conversion

    Common Stock

    2010-03-02$1.13/sh+2,431$2,747112,733 total
Footnotes (4)
  • [F1]Includes 1,785 shares acquired under the Issuer's Employee Stock Purchase Plan on 12/01/09.
  • [F2]The option was issued in connection with the spin-off of the Issuer by Myriad Genetics, Inc. ("MGI") on 06/30/09, pursuant to which each outstanding MGI option was converted into an adjusted MGI option, exercisable for the same number of shares of common stock as the original MGI option, and a new Issuer option, exercisable for one-fourth of the number of shares of common stock as the original MGI option. An adjusted exercise price of each converted option was determined in accordance with Section 409A and Section 422 of the Internal Revenue Code of 1986. All other terms of the converted options remain the same however; the vesting and expiration is based on the optionholder's continuing employment with MGI or the Issuer, as applicable, following the spin-off.
  • [F3]The option vested over a four-year period as to 25% of the shares on each anniversary of 09/14/05, the date of grant of the original MGI option.
  • [F4]The option vested over a four-year period as to 25% of the shares on each anniversary of 02/16/06, the date of grant of the original MGI option.

Issuer

Myriad Pharmaceuticals, Inc.

CIK 0001459450

Entity typeother

Related Parties

1
  • filerCIK 0001191076

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:07 PM ET
Size
11.6 KB